/
Seer, Inc.
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa.
Mentions
2 mentions · latest on 6 Aug 2026
See which tracked investors hold Seer, Inc. →Ownership and position changes on OwnershipTrace
| Giles Capital Reads - Week 31 | - | 6 Aug 2026 | |
| Triple S Special Situations InvestingBlog | Seer | - | 28 Jul 2026 |